COMMUNIQUÉS West-GlobeNewswire

MorphoSys and Galapagos announce U.S. Antitrust Clearance for global license agreement for MOR106 with pharma partner

12/09/2018 - 22:02

Mechelen, Belgium and Planegg/Munich, Germany; 12 September 2018; 22.01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) and MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; NASDAQ: MOR) announced today the [...]

Xenon Pharmaceuticals Announces Proposed Public Offering of Common Shares

12/09/2018 - 22:01

BURNABY, British Columbia, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage, neurology-focused biopharmaceutical company, today announced that it has commenced an [...]

Progenics Pharmaceuticals Reports Top Line Phase 3 Data for Prostate Cancer Imaging Agent 1404

12/09/2018 - 22:01

-Meets Co-Primary Endpoint of Specificity; 1404 Successfully Identifies Patients Without Clinically Significant Prostate Cancer- -Co-Primary Endpoint of Sensitivity to Identify Patients with Clinically Significant [...]

Présentation corporative de Pediapharm

12/09/2018 - 21:52

NE PAS DISTRIBUER AUX SERVICES DE TRANSMISSION DE NOUVELLES DES ÉTATS-UNIS NI DIFFUSER AUX ÉTATS-UNIS. LE NON-RESPECT DE CETTE RESTRICTION PEUT CONSTITUER UNE VIOLATION DE LA LÉGISLATION EN VALEURS MOBILIÈRES DES ÉTATS- [...]

Pediapharm Files Corporate Presentation

12/09/2018 - 21:17

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW. MONTREAL, Sept. 12, [...]

Intermountain Healthcare Now Delivers the Nation’s First “One Stick” Hospitalization for Inpatient Blood Draws

12/09/2018 - 18:06

Intermountain, investing in human-centered quality improvements, sets the new clinical standard for safer, more efficient, and more humane blood collection Salt Lake City, UTAH, Sept. 12, 2018 (GLOBE NEWSWIRE) -- As [...]

THE NINTH EDITION OF THE INTERNATIONAL PRIZE FOR SCIENTIFIC RESEARCH ARRIGO RECORDATI HAS ANNOUNCED THE CALL FOR NOMINATIONS

12/09/2018 - 17:47

The 2019 € 100.000 Award will be dedicated to the promotion and recognition of excellence in orphan disease treatment research . Milan, September 2018 The International Prize for Scientific Research Arrigo Recordati has [...]

PSIQ Announces “No Toxic Debt and No Reverse Stock Split”

12/09/2018 - 16:00

SUNRISE, Fla., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) is pleased to announce the company is without toxic debt and there will be no reverse stock split of PSIQ common stock in the [...]

FibroGen Receives Fast Track Designation From the U.S. FDA for Pamrevlumab for the Treatment of Idiopathic Pulmonary Fibrosis

12/09/2018 - 15:30

SAN FRANCISCO, Sept. 12, 2018 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN), a biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the [...]

REDUCE-IT™ Trial Primary Results Accepted for Presentation at 2018 Scientific Sessions of American Heart Association

12/09/2018 - 15:21

Topline Results of the REDUCE-IT Study Anticipated Before End of September 2018 BEDMINSTER, N.J. and DUBLIN, Ireland, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company [...]

FDA Approves Start of Innovative On-Ambulance Phase 2 Clinical Trial for Treatment of Acute Stroke by Diffusion Pharmaceuticals

12/09/2018 - 15:00

Trial to be Led by Experts from University of California Los Angeles (UCLA) and University of Virginia (UVA) To Expand Treatment Window, Improve Patient Outcomes for Stroke CHARLOTTESVILLE, Va., Sept. 12, 2018 (GLOBE [...]

Constellation Pharmaceuticals Congratulates Dr. David Allis and Dr. Michael Grunstein, Winners of the 2018 Lasker Award

12/09/2018 - 15:00

CAMBRIDGE, Mass., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , Inc. (Nasdaq: CNST) today congratulated Dr. C. David Allis and Dr. Michael Grunstein, the co-recipients of the 2018 Albert Lasker [...]

Segra International Partners With Supreme Cannabis to Support Expansion Efforts Leading Into Legalization

12/09/2018 - 15:00

VANCOUVER, British Columbia, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Segra International Corp. (“Segra” or the “Company”) is pleased to announce that it has entered into an agreement with The Supreme Cannabis Company (“ [...]

Distribution Could Determine Winners in Recreational Cannabis Market -- CFN Media

12/09/2018 - 15:00

SEATTLE, WA, Sept. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication [...]

BrainStorm to Present at FDA and Scientific Workshops Highlighting Innovation in ALS Trial Designs and Continued Progress with NurOwn® Cellular Therapy Platform

12/09/2018 - 14:49

NEW YORK and PETACH TIKVAH, Israel, Sept. 12, 2018 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for debilitating neurodegenerative diseases, [...]

Abeona Therapeutics Announces Authorization to Commence Phase 1/2 Gene Therapy Clinical Study for Patients with MPS IIIB in Spain

12/09/2018 - 14:45

Clinical trial for ABO-101 (AAV-NAGLU) marks the 2nd MPS III program in Europe Company plans to initiate additional clinical sites in European countries including France, Germany and the United Kingdom NEW YORK and [...]

Cambrex Completes Acquisition of Halo Pharma

12/09/2018 - 14:45

EAST RUTHERFORD, N.J., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced it has [...]

The medical condition 72 percent of Americans don’t know about is stealing sleep and disrupting lives, survey shows

12/09/2018 - 14:30

Over one-third of Americans wake up more than once per night to urinate due to a condition called nocturia, which can cause daytime tiredness and irritability, impair work productivity, increase risk of falls and injury [...]

Daxor Corporation to Exhibit at the 22nd Annual Scientific Meeting of the Heart Failure Society of America

12/09/2018 - 14:30

NEW YORK, Sept. 12, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement today [...]